Safety and Efficiency of Photodynamic Therapy for Rectal Cancer — PDT-R-01

Advanced Rectal Cancer Clinical Trial

Official title:
Longterm Outcome of Photodynamic Therapy Compared With Chemotherapy Alone in Patients With Advanced Rectal Cancer

Status Suspended

Clinical Trial Summary

This research is a prospective randomized controlled trial.It aimed to determine longterm outcomes and factors associated with increased survival after photodynamic therapy (PDT) through colonscopy compared with chemotherapy alone in patients presenting with advanced rectal cancer.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01872104
Study type	Interventional
Source	Central South University
Contact
Status	Suspended
Phase	Phase 2/Phase 3
Start date	August 2013
Completion date	August 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03156036` - Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC	Phase 2
Active, not recruiting	`NCT03781323` - Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer	Phase 2
Recruiting	`NCT05228431` - Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer	Phase 2
Active, not recruiting	`NCT02031939` - Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	Phase 3
Not yet recruiting	`NCT05359406` - A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis	Phase 2
Not yet recruiting	`NCT05359393` - A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis	Phase 2